4//SEC Filing
Shendelman Shoshana 4
Accession 0001209191-22-044466
CIK 0001697532other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:40 PM ET
Size
26.9 KB
Accession
0001209191-22-044466
Insider Transaction Report
Form 4
Shendelman Shoshana
DirectorPresident and CEO10% Owner
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−234,616→ 0 totalExercise: $3.33Exp: 2032-01-25→ Common Stock (234,616 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−101,670→ 0 totalExercise: $23.15Exp: 2030-12-10→ Common Stock (101,670 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+101,670→ 101,670 totalExercise: $1.05Exp: 2030-12-10→ Common Stock (101,670 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+134,979→ 134,979 totalExercise: $1.05Exp: 2029-12-16→ Common Stock (134,979 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−607,484→ 0 totalExercise: $10.00Exp: 2029-05-12→ Common Stock (607,484 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+607,484→ 607,484 totalExercise: $1.05Exp: 2029-05-12→ Common Stock (607,484 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+234,616→ 234,616 totalExercise: $1.05Exp: 2032-01-25→ Common Stock (234,616 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−134,979→ 0 totalExercise: $22.20Exp: 2029-12-16→ Common Stock (134,979 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02−23,317→ 0 totalExercise: $22.20From: 2019-12-16Exp: 2029-12-16→ Common Stock (23,317 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2022-08-02+23,317→ 23,317 totalExercise: $1.05From: 2019-12-16Exp: 2029-12-16→ Common Stock (23,317 underlying)
Footnotes (5)
- [F1]The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
- [F2]These Options are fully vested.
- [F3]Reflects an initial grant of 256,850 Options granted on December 10, 2020 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F4]Reflects an initial grant of 209,000 Options granted on December 16, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on December 16, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
- [F5]Reflects an initial grant of 767,349 Options granted on May 13, 2019 that vests as follows: One-fourth (1/4th) of the shares subject to the Option shall vest on May 13, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001775490
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 8:40 PM ET
- Size
- 26.9 KB